Prognostic Value of Serum Neurofilaments in Patients with Clinically Isolated Syndromes

Prognostic Value of Serum Neurofilaments in Patients with Clinically Isolated Syndromes

Bibliographic Details
Main Author:	İpek Güngör Doğan
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2019-09-01
Series:	Türk Nöroloji Dergisi
Subjects:	Multiple sclerosis clinically definite multiple sclerosis clinically isolated syndrome neurofilament light chain
Online Access:	http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-97720

Similar Items

Changes in serum neurofilament light chain levels following narrowband ultraviolet B phototherapy in clinically isolated syndrome
by: Marzena J. Fabis‐Pedrini, et al.
Published: (2022-02-01)

CSF-Progranulin and Neurofilament Light Chain Levels in Patients With Radiologically Isolated Syndrome—Sign of Inflammation
by: Marc Pawlitzki, et al.
Published: (2018-12-01)

Blood Neurofilament Light Chain: The Neurologist’s Troponin?
by: Simon Thebault, et al.
Published: (2020-11-01)

Cerebrospinal fluid neurofilament light chains and CXCL13 as predictive factors for clinical course of multiple sclerosis
by: Pavel Hradilek, et al.
Published: (2023-03-01)

Annual Plasma Neurofilament Dynamics Is a Sensitive Biomarker of Disease Activity in Patients with Multiple Sclerosis
by: Miriam Fedičová, et al.
Published: (2023-04-01)

Demographic and disease‐related factors impact on cerebrospinal fluid neurofilament light chain levels in multiple sclerosis
by: Kamila Zondra Revendova, et al.
Published: (2023-01-01)

Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
by: Dejan Jakimovski, et al.
Published: (2020-09-01)

Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis
by: Cecilia Rajda, et al.
Published: (2020-04-01)

A rapid review of differences in cerebrospinal neurofilament light levels in clinical subtypes of progressive multiple sclerosis
by: Haritha L. Desu, et al.
Published: (2024-04-01)

Síndrome clínico aislado: diagnóstico y riesgo de desarrollar esclerosis múltiple clínicamente definida
by: J. López-Gómez, et al.
Published: (2023-11-01)

Factors Related to the Progression of Clinically Isolated Syndrome to Multiple Sclerosis: A Retrospective Study in Lithuania
by: Renata Balnytė, et al.
Published: (2022-08-01)

Serum neurofilament light chains in progressive multiple sclerosis patients treated with repeated cycles of high-dose intravenous steroids
by: Lidia Stork, et al.
Published: (2023-10-01)

Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management
by: Mark S. Freedman, et al.
Published: (2024-03-01)

Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment
by: Angelo Ghezzi, et al.
Published: (2023-09-01)

Application value of plasma Neurofilament light combined with magnetic resonance imaging to comprehensively evaluate multiple sclerosis activity and status
by: Feiyue Mi, et al.
Published: (2023-11-01)

Serum Neurofilaments and OCT Metrics Predict EDSS-Plus Score Progression in Early Relapse-Remitting Multiple Sclerosis
by: Vlad Eugen Tiu, et al.
Published: (2023-02-01)

The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis
by: Borros Arneth, et al.
Published: (2022-10-01)

DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF INTRATHECAL SYNTHESIS OF IMMUNOGLOBULIN FREE LIGHT CHAINS IN MULTIPLE SCLEROSIS
by: V. D. Nazarov, et al.
Published: (2015-06-01)

Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort studyResearch in context
by: Harald Hegen, et al.
Published: (2023-05-01)

The diagnostic significance of neurofilament heavy chains in cerebrospinal fluid in amyotrophic lateral sclerosis
by: Anastasia V. Vladykina, et al.
Published: (2021-03-01)

Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndromeResearch in context
by: Sander J. van Tilburg, et al.
Published: (2024-04-01)

Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies
by: André Huss, et al.
Published: (2020-08-01)

The Value of Blink Reflex in Early Diagnosis of Multiple Sclerosis
by: Lidija Dežmalj Grbelja, et al.
Published: (2021-01-01)

Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model
by: Tianrong Yeo, et al.
Published: (2022-10-01)

Serum Neurofilaments in Motor Neuron Disease and Their Utility in Differentiating ALS, PMA and PLS
by: Gavin McCluskey, et al.
Published: (2023-05-01)

Plasmodium Vivax-Precipitated Neurological Symptoms: Central Nervous System Idiopathic Inflammatory Demyelinating Disease/Multiple Sclerosis
by: Ahmet Kasım Kılıç, et al.
Published: (2017-12-01)

Predictive value of brain atrophy, serum biomarkers and information processing speed for early disease progression in multiple sclerosis
by: Magdalena Oset, et al.
Published: (2023-07-01)

Value contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis
by: Enric Monreal, et al.
Published: (2024-04-01)

Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis
by: Enric Monreal, et al.
Published: (2023-10-01)

A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis
by: Anna Pafiti, et al.
Published: (2023-06-01)

Isolated Complete Horizontal Gaze Palsy and Multiple Sclerosis
by: Hakan Tekeli, et al.
Published: (2015-04-01)

Decreased Serum Neurofilament Light Chain and Fatigue Severity in Patients with Multiple Sclerosis after Home-Based and Outdoor Pilates Training
by: faranak Balaghi Inaloo, et al.
Published: (2023-05-01)

Evaluation of Diffusion Tensor Imaging Findings in Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis Patients
by: Özkan Alataş, et al.
Published: (2023-04-01)

Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis
by: Agnieszka Kulczyńska-Przybik, et al.
Published: (2022-07-01)

Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis
by: Igal Rosenstein, et al.
Published: (2022-08-01)

Neurochemical Changes in the Brain and Neuropsychiatric Symptoms in Clinically Isolated Syndrome
by: Wojciech Guenter, et al.
Published: (2020-12-01)

Pediatric multiple sclerosis: a review
by: Raed Alroughani, et al.
Published: (2018-03-01)

Spectrum of acute central nervous system demyelinating diseases
by: Bharathkanth Reddy M1 , Ranjith Kumar P2 , P.L John Israel3
Published: (2017-04-01)

Functional Characterization of Neurofilament Light Splicing and Misbalance in Zebrafish
by: Doris Lou Demy, et al.
Published: (2020-05-01)

Detection of Neurofilament Light Chain with Label‐Free Electrolyte‐Gated Organic Field‐Effect Transistors
by: Kateryna Solodka, et al.
Published: (2022-04-01)